Eventide Asset Management’s VectivBio Holding AG Ordinary Shares VECT Stock Holding History

Eventide Asset Management’s Portfolio VECT Stock Details VECT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,675,644	Closed	-$31.6M	–	161
2023 Q1	$31.6M	Buy	3,675,644 +270,000	+8%	+$2.23M	0.58%	59
2022 Q4	$29.3M	Buy	3,405,644 +1,066,600	+46%	+$8.59M	0.58%	57
2022 Q3	$14M	Hold	2,339,044	–	–	0.28%	93
2022 Q2	$12.6M	Hold	2,339,044	–	–	0.27%	92
2022 Q1	$11M	Hold	2,339,044	–	–	0.17%	108
2021 Q4	$11.2M	Hold	2,339,044	–	–	0.14%	110
2021 Q3	$17.6M	Sell	2,339,044 -2,383	-0.1%	-$20.4K	0.23%	103
2021 Q2	$26.6M	Buy	+2,341,427	New	+$35.5M	0.36%	77

Other funds holding VECT

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Eventide Asset Management's VECT Position: Q2 2023 in Review

Eventide Asset Management sold out of VectivBio Holding AG Ordinary Shares (VECT) in Q2 2023, closing a stake of 3,675,644 shares — an estimated $31.6M sold.

Eventide Asset Management first reported a position in VECT in Q2 2021 and held it in 8 quarters. The position peaked at $31.6M in Q1 2023. 49 funds tracked by Wall St. Rank hold VECT as of Q2 2023.

Eventide Asset Management reported no remaining VectivBio Holding AG Ordinary Shares position as of Q2 2023 after selling out during the quarter.
Eventide Asset Management sold 3,675,644 VectivBio Holding AG Ordinary Shares shares in Q2 2023, an estimated $31.6M.
Eventide Asset Management first reported a position in VectivBio Holding AG Ordinary Shares in Q2 2021 and held it in 8 quarters.
Eventide Asset Management's VectivBio Holding AG Ordinary Shares position peaked at $31.6M in Q1 2023.
49 funds tracked by Wall St. Rank held VectivBio Holding AG Ordinary Shares as of Q2 2023.

Based on Eventide Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.